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Abstract
Background: Perturbations of the intrauterine environment can affect fetal development during critical periods of plasticity,
and can increase susceptibility to a number of age-related diseases (e.g., type 2 diabetes mellitus; T2DM), manifesting as late
as decades later. We hypothesized that this biological memory is mediated by permanent alterations of the epigenome in
stem cell populations, and focused our studies specifically on DNA methylation in CD34+ hematopoietic stem and
progenitor cells from cord blood from neonates with intrauterine growth restriction (IUGR) and control subjects.
Methods and Findings: Our epigenomic assays utilized a two-stage design involving genome-wide discovery followed by
quantitative, single-locus validation. We found that changes in cytosine methylation occur in response to IUGR of moderate
degree and involving a restricted number of loci. We also identify specific loci that are targeted for dysregulation of DNA
methylation, in particular the hepatocyte nuclear factor 4a (HNF4A) gene, a well-known diabetes candidate gene not
previously associated with growth restriction in utero, and other loci encoding HNF4A-interacting proteins.
Conclusions: Our results give insights into the potential contribution of epigenomic dysregulation in mediating the long-
term consequences of IUGR, and demonstrate the value of this approach to studies of the fetal origin of adult disease.
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Introduction
The concept of fetal origin of adult disease suggests that early
life conditions can ‘‘program’’ the fetus for a spectrum of adverse
health outcomes as an adult [1]. The link between intrauterine
growth restriction (IUGR) and adult diseases such as type 2
diabetes and cardiovascular disease has been extensively supported
by epidemiological [2,3,4,5,6,7] and animal [8,9,10,11] studies.
To date, reports have focused on characterizing the pathophys-
iological consequences of an adverse intrauterine environment,
and have revealed dysregulation of gene expression and a variety
of functional impairments in individual tissues (including liver
[12,13], skeletal muscle [4,14], pancreas [15,16], kidney [17], and
bone [18]) that precede and are potentially contributory to a range
of later adult diseases. Taken together, these studies define a
precocious aging phenotype, culminating in an increased risk of
premature death [10,19].
Permanent and sometimes progressive changes in gene expression
have been observed in multiple tissues as a consequence of IUGR
[16,17,20,21]. Dysregulation of the epigenome may explain changes
that are propagated from parent to daughter cells in IUGR offspring
throughout life. For instance, offspring of rats fed a restricted protein
diet throughout pregnancy showed changes in DNA methylation at
multiple genes, with corresponding changes in gene expression, both
of which were prevented by maternal supplementation of folic acid
(an important methyl donor), further implicating an epigenetic
mechanism [22,23,24]. Additionally, human studies also demon-
strated epigenetic differences in response to an adverse intrauterine
environment, as periconceptional exposure to famine was associated
with altered DNA methylation at multiple sites within the known
IGF2 differentially methylated region (DMR) [25]. Similar epige-
netic dysregulation has been observed in a variety of tissues
[23,24,26,27], consistent with IUGR-induced susceptibility to age-
related diseases affecting multiple organ systems.
As the life-long progenitors of many differentiated lineages, stem
cells must act as custodians of epigenomic regulatory patterns in
order that these changes persist in most tissues throughout the
lifetime of an organism. Hematopoietic stem (CD34+) cells are one
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neonatally accessible population, present as ,1% of mononucle-
ated umbilical cord blood cells [28]. Following tissue injury, this
stem cell population is able to mobilize, proliferate, and home to
target microenvironments at the site of damage [29], and may
coordinate injury repair by stimulating tissue-specific progenitors
[30,31]. Moreover, these stem cells are multipotent progenitors of
the immune system, which itself is likely to mediate inflammation,
development, and progression of T2DM and cardiovascular
disease [32].
To determine whether an adverse intrauterine environment
leads to epigenetic changes that have functional pathological
consequences, we studied DNA methylation in multipotent
hematopoietic (CD34+) stem cells of IUGR neonates and matched
controls. We employed our new, high-resolution version of the
microarray-based HELP assay [33] to study ,1.32 million loci
throughout the human genome. Rather than focus on known
candidate loci, we expanded the search genome-wide to identify
novel loci involved and also tested for global, non-specific effects of
IUGR on cytosine methylation. We followed this screening
approach with a second stage of analysis, validating methylation
status using quantitative, nucleotide-resolution bisulphite MassAr-
ray [34] to define the dysregulatory effects of IUGR on the
epigenome.
Methods
This study was approved by the institutional review board (IRB)
of the Montefiore Medical Center and the Committee on Clinical
Investigation at the Albert Einstein College of Medicine and is in
accordance with Health Insurance Portability and Accountability
Act (HIPAA) regulations. Written informed consent was obtained
from all subjects prior to participation.
Clinical Data Collection and Identification of Cases and
Controls
Biological samples and clinical information were collected from
consenting women who delivered IUGR or infants with
appropriate growth (matched for gestational age at delivery,
ethnicity and gender). Both birth weight and ponderal index (a
measurement of neonatal weight relative to length) were used to
identify cases and controls. IUGR had birth weight and ponderal
index ,10th percentile for gestational age and gender and
controls had normal percentiles (.10th and ,90th) for both
parameters. Pertinent data on maternal medical history, pregnan-
cy complications and neonatal hospital stay were recorded.
Isolation of CD34+ Cells
CD34+ cells, which constitute approximately 1% of nucleated
blood cells in umbilical cord blood [28], were isolated from the
cord blood specimen using an immunomagnetic separation
technique, as previously described [35]. Mononuclear cells are
separated by Ficoll-Paque density gradient, following which
CD34+ cells are obtained by positive immunomagnetic bead
selection, using Macs columns (Miltenyi Biotech). The isolated
cells having .95% purity [36,37] are cryopreserved in 10%
DMSO by controlled rate freezing.
HELP Assay
High-resolution HELP assays were performed according to
recent advances in the technology [33]. Genomic DNA was
isolated, digested to completion by either HpaII or MspI
separately, and then ligated to a mixture of two oligonucleotide
pair adapters, each complementary to the cohesive ends generated
by the restriction digest. The adapters then served as a priming site
for a PCR reaction (ligation-mediated PCR, LM-PCR) that we
have described to generate a product predominantly in the 50–
2,000 bp size range [33]. Following PCR, the HpaII and MspI
representations were labeled with different fluorophores using
random priming and were then cohybridized on a customized
genomic microarray representing ,1.32 million HpaII/MspI
fragments of 50–2,000 bp in unique sequence [33].
Data Analysis
Microarray data were pre-processed and subject to quality
control and quantile normalization as previously described [38].
HpaII/MspI ratio values were compared between groups for all
loci throughout the genome using a paired t-test with cases (n=5)
and controls (n=5) matched by gender and gestational age, as well
as ethnicity where possible (see Table S1). Changes in
methylation state were defined using a HpaII/MspI ratio
threshold of zero, where methylated loci and hypomethylated loci
had ratio values less than zero and greater than zero, respectively.
Ordered lists of differences were generated, the first relying purely
on paired t-test computed p-values. Our alternative approach
identified differential methylation, ranked according to the
formula: {log p ðÞ x IURG { control jj : This method, similar to
the modified T test [39], places more weight on the fold-change
relative to the within group variability. However, unlike p-values
based on the modified T test, computed values are not interpreted
in these studies as a probabilistic quantity, and instead are used
exclusively to rank and isolate important loci.
Bisulphite MassArray Validation
Target regions were amplified by PCR using the primers and
cycling conditions described in Table S2. Primers were selected
with MethPrimer (http://www.urogene.org/methprimer/) using
parameters as follows: 200–400 bp amplicon size, 56–60uC Tm,
24–30 bp length, and $1 CG in product. 50 ml PCR reactions
were performed using the Roche FastStart High Fidelity Kit. In
cases where products showed primer-dimer or other contaminants,
bands of appropriate size were excised from 2% agarose gels,
purified by Qiagen Gel Extraction Kit, and eluted with 1X Roche
FastStart High Fidelity Reaction Buffer (+MgCl2). All PCR
products (5 ml) were aliquotted onto 384-well microtiter plates
and were treated with 2 ml of Shrimp Alkaline Phosphatase (SAP)
mix for 20 minutes at 37uC to dephosphorylate unincorporated
dNTPs. Microtiter plates were processed by the MassArray Matrix
Liquid Handler. A 2 ml volume of each SAP-treated sample was
then heat-inactivated at 85uC for 5 minutes and subsequently
incubated for 3 hours at 37uC with 5 ml of Transcleave mix (T or
C Cleavage Mix) for concurrent in vitro transcription and base-
specific cleavage. Samples were transferred onto the spectroCHIP
array by nanodispensation calibrated to ambient temperature and
humidity, and analysis with the Sequenom MALDI-TOF MS
Compact Unit following 4-point calibration with oligonuculeotides
of different mass provided in the Sequenom kit. Matched peak
data was exported using EpiTYPER software and analyzed for
quality and single nucleotide polymorphisms according to
analytical tools that we have recently developed [40].
Ingenuity Pathway Analysis
The most significantly differentially methylated loci were
mapped to RefSeq gene identifiers by chromosomal position
within 10 kb upstream of the transcription start site or overlapping
the gene body. The list of RefSeq identifiers was then uploaded to
the Ingenuity Pathway Analysis program (Redwood City, CA),
enabling exploration of ontology and molecular interaction
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corresponding gene object (focus genes) in the Ingenuity Pathways
Knowledge Base. Core networks were constructed for both direct
and indirect interactions using default parameters, and the focus
genes with the highest connectivity to other focus genes were
selected as seed elements for network generation. New focus genes
with high specific connectivity (overlap between the initialized
network and gene’s immediate connections) were added to the
growing network until the network reached a default size of 35
nodes. Non-focus genes (those that were not among our
differentially methylated input list) that contained a maximum
number of links to the growing network were also incorporated.
The ranking score for each network was then computed by a
right-tailed Fisher’s exact test as the negative log of the probability
that the number of focus genes in the network is not due to
random chance. Similarly, significances for functional enrichment
of specific genes were also determined by the right-tailed Fisher’s
exact test, using all input genes as a reference set.
Results
Gestational and Neonatal Clinical Parameters in IUGR and
Controls
Umbilical cord blood samples were collected from 10 well-
matched, consenting individuals: IUGR (n=5), and appropriate
for gestational age controls (n=5), matched for gestational age at
delivery, gender, and ethnicity). We controlled for variable cellular
composition of mixed leukocyte populations in the cord blood by
purifying for hematopoietic stem (CD34+) cells, which served as a
reference cell type for comparison in all subjects, thus reducing this
potential source of variability which could have otherwise
influenced our subsequent methylation assays [41]. We also note
that while CD34+ cells are functionally heterogeneous themselves
[42], purification reduces cell-specific variability in cytosine
methylation that could otherwise mask (or artificially create)
IUGR-related changes.
By design, IUGR weighed less and had a lower ponderal index
than their matched controls, which were required to have normal
percentiles for birth weight and ponderal index (Table 1). Both
groups had similar gestational age at delivery and proportions of
each sex and ethnic composition, and comparable maternal age,
BMI, pregnancy weight gain, and 1-hour maternal plasma glucose
screen values after a 50 g glucose load (Table 1). All of the
women and their infants were healthy. None of the mothers had
chronic hypertension, pre-eclampsia or gestational hypertension,
pre-gestational or gestational diabetes, renal or autoimmune
disease. The neonates had similar 1-minute and 5-minute Apgar
scores in both groups (data not shown). One infant in the IUGR
group had unilateral mild pyelectasis, which did not require
treatment. There were no other neonatal complications.
Distinct Patterns of DNA Methylation in IUGR and Control
Subjects
To detect global patterns of epigenetic changes that could
distinguish between IUGR and controls, we performed the HELP
assay on the CD34+ cells. These genome-wide cytosine methylation
profiles are available as a public resource through http://greallylab.
aecom.yu.edu/,greally/humanIUGR/ and through the GEO
repository (accession number GSE17727). We compared the full
dataset of HELP data from IUGR and normal birthweight subjects
using unsupervised clustering. We observed consistent patterns of
methylation across all samples, without any apparent global changes
in methylation status (e.g. the hypomethylation commonly seen in
cancer [43]) between IUGR and control groups (Figure S1).
Global Pearson correlation coefficients were calculated for the
methylation patterns for each pair of samples, confirming a high
degree of inter-sample consistency (R=0.9020.95).
We tested to see whether cytosine methylation changes were
present but undetected in global comparisons because they occur at
only a subset of loci and/or to a limited degree at each locus. Paired
T tests were applied to detect group differences for all individual loci
represented on our arrays. This analysis yielded a subset of
potentially informative loci with statistically significant differences
in methylation. Figure 1A shows the distribution of p-values
observed for IUGR compared to controls. Figure 1B shows the
distribution of p-values when class labels are randomly permuted
once across all loci and are representative of what we would see
under the null distribution of no group effect. This illustrates how
the observed p-values for the IUGR/control comparison are
associated with a distribution consistent with lower than expected
p-values for a small subset of loci, with 56 candidate loci (Table 2)
having significant group differences (p,0.00001, chosen because no
test statistics derived under any other permutation obtained a p-
value below 0.000015), and an additional 646 loci with moderate
group differences (p,0.0001).
For comparison, p-value distributions calculated for grouping by
gender and ethnicity are shown in Figures S2A and S2B,
respectively. Gender comparison shows ,2,500 significant loci
(p,0.00001 threshold), an expected outcome due to the vast
majority of these discriminatory loci (99.4%) being located on the X
and Y chromosomes. We found no evidence for ethnicity (Latino
versus non-Latino) influencing cytosine methylation (Figure S2B).
When we looked in detail at the 56 differentially-methylated
loci, we found that the magnitude of DNA methylation changes
observed in IUGR compared to controls is markedly less than
many tissue-specific differences in methylation that we have
previously observed ([44]; and data not shown). Furthermore, we
analyzed methylation status at four known imprinted regions on
chromosome 11, some of which have been shown to harbor small
changes in methylation in subjects with IUGR (the IGF2
differentially-methylated region (DMR), the H19 DMR and
promoter region, and the KCNQ1 DMR) [25,45] but found no
detectable differences in the IUGR group compared to controls in
this particular cell type (data not shown).
Validation Studies on Selected Candidate Loci
The next component of our two-stage experimental design was
to validate the HELP data with single-locus, nucleotide-resolution
Table 1. Neonatal and Maternal Characteristics for IUGR and
Controls.
Neonatal and Maternal Characteristics IUGR Controls
(n=5) (n=5)
Gestational age, weeks (mean 6SD) 39.960.2 40.260.6
Birthweight, g (mean6SD) 24936270 32406276
*
Ponderal index, g/cm
3 (mean6SD) 2.360.08 2.8160.1
*
% Male 40 40
Maternal age, years (mean 6SD) 23.665.7 22.864.7
Pre-pregnancy BMI, kg/m
2 (mean6SD) 24.563.2 25.167.5
Weight gain, pounds (mean6SD) 32614 2667
1-hour glucose screen, mg/dL (mean6SD) 93.8625 74.3626
*p,0.05 compared to matched cases.
doi:10.1371/journal.pone.0008887.t001
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To choose the loci for validation, we assessed the candidacy of the
top 56 loci in terms of related biological function, reasoning that
epigenetic dysregulation of the small degrees we were observing
would have to affect multiple components of a biological pathway
to cause functionally-significant changes. We used an Ingenuity
Pathway Analysis (IPA) for 33 of the top 56 candidate loci, chosen
because of physical proximity to 35 RefSeq-annotated genes (22
promoters and 13 gene bodies). While the remaining 23/56 loci in
intergenic regions could not be linked to genes using these
proximity criteria, almost half of these loci occur at CG clusters
[46] or phastCons conserved DNA elements [47], both charac-
teristics having potential relevance as cis-regulatory sites [48] and
therefore may have unrecognized roles regulating transcription.
Of the two highest-scoring molecular interaction networks
generated from IPA analysis, one was associated with cell
signaling, nucleic acid metabolism, and molecular transport
(Figure S3), while the other network contained 12 out of 35
input nodes and was functionally associated with the cell cycle,
cellular maintenance, and connective tissue development
(Figure 2). Moreover, this network was centered primarily on
the hepatic nuclear factor 4a (HNF4A), a transcription factor that
has been strongly implicated in an early-onset form of type II
diabetes, maturity onset diabetes of the young [49]. Although
HNF4A did not meet our strict threshold for significance in the
primary analysis, it was ranked first in our secondary analysis using
a test statistic that was more heavily weighted towards the mean
shift between groups (see Methods).
An additional IPA that was applied specifically to candidate
loci overlapping RefSeq gene promoters revealed a third
molecular interaction network including 17 of 23 input nodes.
This network is functionally associated with cancer, cellular
development, cellular growth and proliferation (Figure S4), and
is centered on a number of transcription factors and growth
hormones (e.g. NCOR2, GH1, TGFb1, HNF4A), and TP53 which
shows altered DNA methylation in renal tissue of IUGR rats in
adult life [26].
We therefore proceeded to bisulphite MassArray experiments
[34], initially testing the technical performance of the HELP assays
by choosing four loci, two each representing constitutively
hypomethylated and constitutively methylated sites identified by
the HELP assay. Figure S5 demonstrates the agreement between
methylation values determined independently for these loci by
HELP and MassArray (with a between-assay correlation in this
case of R=20.96353).
The technical validation results confirmed that the HELP data
were accurate and allowed us to proceed to the analysis of the
specific loci at which dysregulation of cytosine methylation was
suspected. We focused on the HNF4A locus, where HELP data
showed evidence for changes in cytosine methylation at an internal
promoter of this complex gene (Figure 3). Furthermore, the
identified locus represents highly conserved sequence and contains
multiple known transcription factor binding sites for HNF1a and
b, SP1, HNF6, and GATA6 [50]. Differences in DNA
methylation at the HNF4A promoter were confirmed by
MassArray, with the informative HpaII site showing hypermethy-
lation in IUGR compared to controls (65.7% and 59.6%
methylation, respectively; p,0.01), consistent with the HELP
data (log2(HpaII/MspI)=1.8960.42 and 3.4660.60, respectively;
p=0.00006). This increased methylation level is of a magnitude
comparable with that observed in samples from the Dutch famine
cohort [25]. Functionally, the acquisition of cytosine methylation
at this promoter may reduce HNF4A expression in IUGR
offspring, consistent with the inherited loss-of-function mutations
Figure 1. Supervised group comparisons reveal significant differences in HELP data results between IUGR and controls. Panel (A)
shows a histogram distribution of p-values calculated from an unpaired T test of IUGR (n=5) in one group and controls (n=5) in another. The x axis
represents p values, with lower values being the more significant, while the y axis shows the frequency of occurrence of different p values. The peak
observed represents a subset of loci with low p values and thus significant differences between IUGR and control subjects. For comparison, panel (B)
shows the results of a random distribution of subjects into two groups, mixing IUGR and controls, demonstrating the absence of a subset of loci with
significant p values.
doi:10.1371/journal.pone.0008887.g001
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Position IUGR Control Difference P CpG CGc phC Rep Loc Gene(s) RefSeq
chr2:235526053-235526128 2.06 2.66 20.61 0.4 YES YES YES PRO SH3BP4 NM_014521
chrX:66138356-66139206 20.78 21.29 0.51 0.8 no no no RT
chr15:45018938-45019873 20.62 21.11 0.48 0.9 no no YES
chr6:106879977-106880120 2.56 3.34 20.78 1.1 YES YES YES PRO ATG5 NM_004849
chr18:18624869-18626554 20.72 21.28 0.55 1.3 no no YES
chr2:176841167-176842343 20.16 20.48 0.33 1.5 no YES no LT PRO MTX2 NM_006554
chr6:113687585-113688546 21.81 22.61 0.80 1.5 no no YES
chr11:77123865-77124724 20.60 21.33 0.73 1.8 YES no YES GB RSF1 NM_016578
chrX:70857596-70857847 0.51 1.28 20.77 2.0 no no no
chr19:2616301-2616955 20.86 21.18 0.32 2.2 no no no RT GB GNG7 NM_052847
chr12:123573299-123573372 1.80 2.79 21.00 2.2 no no no PRO NCOR2 NM_006312
chr4:102487593-102487694 1.59 2.55 20.97 2.4 YES YES YES PRO PPP3CA NM_000944
chr11:13612440-13613698 21.01 21.79 0.78 2.5 no no no




chrX:48943071-48943319 1.94 2.72 20.78 3.0 YES YES YES PRO SYP NM_003179
chr12:105961981-105963288 21.44 22.49 1.06 3.1 no no no RT PRO CRY1 NM_004075
chr11:76172201-76172653 2.48 3.16 20.68 3.2 YES YES YES PRO TSKU NM_015516
chr8:318760-319070 21.07 20.60 20.47 3.4 no no no
chr8:25575968-25577680 21.53 22.41 0.88 3.4 no no YES
chrX:99552722-99552801 3.09 3.62 20.52 3.7 YES YES YES PRO PCDH19 NM_020766
chr22:45949018-45950112 21.23 21.87 0.65 3.7 no YES no
chr11:99814353-99814807 20.48 0.36 20.83 3.8 no no no
chr15:91226882-91227081 2.40 3.34 20.93 3.8 no YES YES




chr12:1774845-1774939 1.72 2.45 20.73 4.2 no no no GB CACNA2D4 NM_172364
chr15:88120371-88120587 1.28 2.08 20.79 4.4 YES YES YES PRO MESP2 NM_001039958
chr9:78132928-78133704 20.91 21.56 0.65 5.2 no no YES
chr9:33740402-33740551 1.61 2.41 20.80 5.2 YES YES no PRO PRSS3 NM_007343
chr16:4746813-4747596 21.50 21.85 0.35 5.2 no no no RT GB ZNF500 NM_021646
chr3:129693359-129693420 1.66 2.31 20.65 5.2 YES YES no PRO GATA2 NM_032638
chr2:206657793-206657892 2.47 3.43 20.96 5.4 no YES YES PRO INO80D NM_017759
chr6:21543836-21545402 21.61 22.10 0.49 5.6 no no no RT
chr22:16347210-16348259 21.26 21.62 0.36 5.9 no no no RT GB CECR2 NM_031413
chr8:94370466-94372334 21.26 22.09 0.84 6.1 no no no
chr20:22581679-22582432 21.09 21.76 0.67 6.1 no no YES
chr21:25927844-25929694 21.13 21.77 0.64 6.3 no no YES RT/LT
chr12:105841213-105843079 21.42 21.71 0.29 6.4 no no no RT
chrX:39752669-39752723 1.04 1.99 20.95 6.5 YES YES YES
chr16:87294955-87295022 1.03 1.63 20.60 6.7 no YES no GB RNF166 NM_178841
chr22:17514809-17516325 2.52 3.26 20.74 7.0 YES YES no PRO GSC2 NM_005315
chr15:78244066-78244975 21.04 21.49 0.45 7.1 no no no GB FAH NM_000137
chr10:101825755-101826964 21.72 22.11 0.39 7.2 no no YES PRO CPN1 NM_001308
chr16:29563652-29563719 2.38 3.22 20.83 7.3 no no no RT
chr5:132564040-132565611 21.89 22.55 0.66 7.5 no no YES PRO FSTL4 NM_015082
chr18:40597598-40598729 22.17 22.86 0.69 7.6 no no YES GB SETBP1 NM_015559
chr17:17019265-17021036 21.34 21.94 0.60 7.9 no no YES GB MPRIP NM_015134
chr4:101159747-101160275 21.72 22.38 0.66 8.0 no no no RT
chr11:120258272-120258456 2.13 2.91 20.78 8.1 no no YES PRO GRIK4 NM_014619
Epigenetic Regulation in IUGR
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onset diabetes of the young (MODY) [49].
Effect Size and Power Computations
One of our goals was to use our data post hoc to define how best
to design this kind of study to test the dysregulation of cytosine
methylation in a human disease. We therefore calculated an
estimation of effect size for the top 1,000 loci with differences in
methylation between IUGR and controls. Similar to the
distribution of methylation differences noted for the top 56 loci,
the 1,000 most informative loci had a mean difference of 0.60 with
a standard deviation of 0.20 log2 units. The difference in average
methylation between control and IUGR at all loci measured
tended to be subtle (between 0.20 and 1.00) and less likely to
represent broad methylation state changes (going from a
completely methylated state to a hypomethylated state and vice
versa). We simulated informative genes with this information as a
guide for true group differences in this population (Table 3).
Discussion
We present preliminary evidence for a unifying new hypothesis
in which epigenetic modification induced in early development may
contribute to an increased susceptibility to age-related diseases by
prematurely advancing the normal aging process. Using a genome-
wide, high-resolution cytosine methylation assay (testing ,1.32
million loci throughout the genome), we avoid the necessity for any
ap r i o r iassumptions about candidate loci and reveal potential new
candidates in mediating the fetal origin of adult disease. We
identified dysregulation of DNA methylation in purified populations
of cord blood-derived CD34+ stem cells from IUGR neonates
compared with matched controls, and find that these changes occur
throughout the genome, although they are of a more modest degree
and relatively limited extent compared with the epigenomic
dysregulation observed in conditions such as cancer. As our study
was based on a limited number of subjects, such subtle differences
in cytosine methylation challenge the ability of genome-wide
approaches to identify genuinely significant loci even at standard
significance levels (0.05–0.001) which do not reflect multiple testing.
In large-scale studies, when thousands to millions of loci are
measured, the threshold to declare any locus significant is typically
based on a more stringent level of significance (e.g. Bonferroni
correction or similar) in order to minimize the possibility of false
positives, therefore we have displayed the power at two such
thresholds. Based on these simulations, a more expansive approach,
with sample size of at least 25 subjects per group is recommended
for studies of methylation changes in conditions where such subtle
effects are expected.
Nonetheless, we found that the IUGR subjects were distinctive
for having a number of consistent differences in methylation near
genes involved in processes critical for stem cell function, including
cell cycle and cellular maintenance. Quantitative bisulphite
validation studies confirmed our ability to discriminate differences
in methylation in these samples, and the biological coherence of
results in terms of functional pathway relatedness is suggestive of
underlying changes in epigenetic regulation as a response to
IUGR.
A locus that emerged consistently in this pathway analysis was
the HNF4A gene, already implicated in T2DM [49], but not
previously demonstrated to undergo epigenetic dysregulation as a
response to IUGR. Best known for its implications as a
monogenic, autosomal dominant form of maturity onset diabetes
of the young (MODY) [49], HNF4A is involved in development
and function of both the liver and the pancreas [51] and actively
coordinates gene expression of many important metabolic
pathways in both tissues [52,53,54]. We find differences in DNA
methylation targeted to only one of the HNF4A promoters,
supporting a model of isoform variation of the gene being related
to susceptibility to T2DM, a major age-related disease.
Other loci identified in this study were found to be related
functionally to HNF4A and also include ATG5 and TADA3L,
which may have roles in mediating susceptibility to later disease.
ATG5 is an essential component of autophagy that, when depleted,
renders cells more susceptible to starvation and starvation-induced
cell death [55]. We found that ATG5 is relatively methylated in
IUGR at a CpG island-containing site just downstream of the
transcription start site, potentially reducing expression in IUGR
compared with controls, in parallel with increased sensitivity to
starvation-induced cell death. Transcriptional adaptor 3 (TADA3L)
is associated with and is required for full p53 activity, causing
growth arrest, senescence, and p53-mediated apoptosis [56].
TADA3L isoforms are highly expressed in CD34+ stem cells
[57], but we find that TADA3L is relatively methylated in IUGR at
a CpG island-containing bidirectional promoter, potentially
downregulating its expression and altering CD34+ stem cell
population dynamics.
However, the modest level of differences in methylation that we
and others have observed [25] raises an important question: what
Position IUGR Control Difference P CpG CGc phC Rep Loc Gene(s) RefSeq
chr9:19033554-19034579 20.19 20.84 0.65 8.5 no no no RT
chr8:59144552-59145204 21.10 21.61 0.52 8.6 no no YES GB FAM110B NM_147189
chr6:41861921-41862019 0.99 1.56 20.57 8.7 YES YES YES GB PRICKLE4 NM_013397
chr15:61088671-61090467 20.44 21.03 0.59 8.8 no no no
chr10:71811777-71811840 1.86 2.76 20.90 8.8 YES YES no PRO LRRC20 NM_018205
chr12:109990645-109990725 1.32 2.32 21.00 9.1 no no YES PRO CUX2 NM_015267
chr3:124611357-124611643 3.63 4.23 20.61 9.4 no no YES PRO ADCY5 NM_183357
chr10:92344854-92345619 21.70 22.71 1.01 9.7 no no no
All positions correspond to coordinates in the human genome, hg18 March 2006 UCSC Genome Browser; IUGR and Control data given as group averages of log2(HpaII/
MspI); difference is IUGR minus Control; P-values are all x10
26; CpG, overlap with CpG islands; CGc overlap CG clusters; phC overlap with mammalian or vertebrate
phastCons conserved elements; Rep overlap with repetitive elements (RT for retrotransposable elements including LINEs and SINEs, LT for long terminal repeats); Loc
overlap with promoters (PRO), bidirectional promoters (PRO
2), or gene bodies (GB) of RefSeq genes; Gene names and corresponding RefSeq identifiers are also shown.
doi:10.1371/journal.pone.0008887.t002
Table 2. Cont.
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PLoS ONE | www.plosone.org 6 January 2010 | Volume 5 | Issue 1 | e8887is the biological significance of changes in methylation on the
order of ,6%? We note that such a change must represent a
difference in a proportion of cells and/or alleles undergoing
methylation within the broader population of CD34+ cells.
Because CD34+ stem cells are multipotent progenitors, the
presence of an epigenetically dysregulated subpopulation may go
on to mediate susceptibility to chronic disease, with potentially
greater effects over time should this subpopulation expand.
Alternatively, this stem cell population may serve to define loci
susceptible to constitutive ‘‘epimutations’’ [58] that are likely to
exist in descendent cell types or unrelated lineages (e.g. liver or
pancreatic progenitors) where they may have the chance to induce
functional changes in critical cell types or tissues. Adding further
information about epigenetic and transcriptional regulators other
than cytosine methylation plus transcriptional profiling studies will
be very valuable in gaining a greater understanding of the
epigenetic dysregulation and its functional consequences in IUGR.
We hypothesize that the changes we observe by focused studies of
hematopoietic (CD34+) stem cells are representative of the influence
of the intrauterine environment on epigenetic regulation and
Figure 2. A second molecular interaction network suggested by Ingenuity Pathway Analysis (IPA), with HNF4A as a central node,
consists of 12 genes among the top 56 differentially methylated loci. RefSeq IDs for 33 of the top 56 sites that mapped to genes were
uploaded onto the ‘‘Core Analysis’’ tool of IPA. The second-highest scoring molecular interaction network was constructed by 35 nodes, 12 of which
were located on the input list (shaded nodes), and is associated with the cell cycle, cellular function and maintenance, and connective tissue
development and function. The nodal relationships are indicated by solid lines (direct interaction) and dashed lines (indirect interactions), witho r
without filled arrows indicating functional interaction or merely physical association, respectively. Additionally, filled arrows that are preceded by a
terminal bar indicate inhibition as well as functional interaction. The shape of each node indicates the class of molecule: horizontal ovals are
transcription factors, squares are growth factors, vertical rectangles are ion channels while horizontal rectangles are nuclear receptors, inverted
triangles are kinases, vertical diamonds are enzymes while horizontal diamonds are peptidases, trapezoids are transporters, and circles correspond to
‘‘other’’ molecules. In alphabetical order, this network consists of BUD31, CECR1, Collagen(s), CPN1, CRY1, DHX8, FAM110B, FGF2, GIN1, GRIK4,
HNF4A, INO80D, KNG1, LPIN3, MAP3K3, MPRIP, MRTO4, NOC3L, PPARA, PRICKLE4, PRSS3, RSF1, RUVBL2, SLC31A1, SLC35A1, SLC35A5, SLC39A1,
SMARCA5, SPAST, TGFB1, TSKU, UXT, WRNIP1, XPNPEP2, and ZNHIT6.
doi:10.1371/journal.pone.0008887.g002
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PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8887Figure 3. Differential methylation at the HNF4A locus proximal promoter region. HELP data are shown in (a) as normalized, centered
log2(HpaII/MspI) ratios. A locus with a change in methylation is marked with an asterisk. A more detailed view of this region is shown in (b), showing
conservation of DNA sequences at this alternative promoter of HNF4A. In (c) the degree of difference in cytosine methylation as measured by
bisulphite MassArray is shown with the locus changing to a significant degree shown with its associated p value. This CG dinucleotide is within one of
the HpaII sites of the informative gragment in (a) and is located immediately beside the conserved transcription factor binding sites shown in (b).
These images were derived from the UCSC Genome Browser [60].
doi:10.1371/journal.pone.0008887.g003
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While all cells are believed to accumulate epimutations over time
[59], periods of rapid cell division (e.g. during fetal development)
represent the most vulnerable windows for cellular injury and
potential dysregulation of the epigenome, with associated decreases
in cellular fitness, function, and, of particular note for multipotent
stem cells, replicative capacity. We therefore propose that adverse
intrauterine conditions are more likely to contribute to replicative
senescence and early exhaustion of regenerative pools of stem cell
precursors throughout the body, increasing susceptibility to and
speeding onset of age-related diseases like T2DM.
Although the exact mechanism remains unclear, the results of
this study are indicative of epigenetic dysregulation associated with
intrauterine growth restriction. Moreover, these findings suggest
that epigenetic changes serve as a steward of cellular memory of
aberrant intrauterine environments, and that site-specific changes
in DNA methylation may mediate the increased susceptibility to
age-related diseases observed later in life.
Accession Numbers
GEO database, accession number GSE17727.
Supporting Information
Figure S1 Global correlation using the entire dataset demon-
strates a high degree of epigenetic correlation among all samples,
with no apparent global difference between IUGR and controls. A
tree-pair plot was generated using a visualization tool that we have
developed as part of an R package (Thompson, 2008). Pairwise
correlations, calculated from .1.32 million independent loci, are
shown in the upper right portion of the figure, where R values
indicate the Pearson correlation for each pair of samples (labeled
along the diagonal) and blue dotplots show a visual representation
of the similarity between samples. Thin red lines within each of
these sub-panels correspond to a lowess-fit of the pairwise data. In
the lower left portion of the figure, a tree determined by Ward’s
minimum variance clustering shows an alternative unsupervised
clustering approach. Branching order is shown in solid lines,
colored by group. The diagonal dotted lines are numbered and
indicate the Euclidean distance scale. The dotted red line indicates
the Euclidean distance cutoff used to separate the individual
groups of samples. Thompson, R.F., Reimers, M., Khulan, B.,
Gissot, M., Richmond, T.A., Chen, Q., Zheng, X., Kim, K. and
Greally, J.M. (2008) An analytical pipeline for genomic represen-
tations used for cytosine methylation studies, Bioinformatics, 24,
1161–1167.
Found at: doi:10.1371/journal.pone.0008887.s001 (0.70 MB TIF)
Figure S2 Supervised group comparisons reveal differences in
methylation based on gender but not ethnicity. Panel (A) shows a
histogram distribution of p-values calculated from an unpaired T
test of males (n=4) in one group and females (n=6) in another.
Along the x-axis, leftmost data represent low p-values (i.e. highly
significant differences in methylation between groups), while data
towards the right represent high p-values and, thus, loci that are
uniform across groups. P-value frequency is shown along the y-
axis, with larger values indicating increasing numbers of
differentially methylated loci corresponding to the indicated p-
value level. Note that the y-axis in this panel is adjusted to a
different scale in order to account for the higher frequency of
highly significant p-values. Panel (B) shows an analogous
histogram with data obtained from samples grouped by ethnicity
(Latin, n=7, compared to non-Latin, n=3).
Found at: doi:10.1371/journal.pone.0008887.s002 (0.04 MB TIF)
Figure S3 The top-scoring molecular interaction network
suggested by Ingenuity Pathway Analysis (IPA) consists of 13
genes among the top 56 differentially methylated loci. RefSeq IDs
for 33 of the top 56 sites that mapped to genes were uploaded onto
the ‘‘Core Analysis’’ tool of IPA. The top-scoring molecular
interaction network was constructed by 35 nodes, 13 of which were
located on the input list (shaded nodes), and is associated with cell
signaling, nucleic acid metabolism, and molecular transport. The
nodal relationships are indicated by solid lines (direct interaction)
and dashed lines (indirect interactions), with or without filled
arrows indicating functional interaction or merely physical
association, respectively. The shape of each node indicates the
class of molecule: horizontal ovals are transcription factors, squares
are cytokines, vertical rectangles are G-protein coupled receptors,
triangles are phosphatases, diamonds are enzymes, trapezoids are
transporters, small ovals are chemicals, and circles correspond to
‘‘other’’ molecules. In alphabetical order, this network consists of
ADCY, ADCY5, ADCY9, ARPC4, ATG5, b-estradiol, CAP2,
CRYM, CUX2, EMILIN3, FSH, GALR1, GALR3, GH1, GJA1,
GNAI2, GNAL, GNG7, GSTM3, HTR1F, LPAR4, MAMLD1,
5-methoxytryptamine, MllRN181C, NCOR2, noladin ether,
PALM, PCDH19, PPP3CA, RXFP4, SH3BP4, SYP, TADA3L,
and TP53.
Found at: doi:10.1371/journal.pone.0008887.s003 (0.32 MB TIF)
Figure S4 A molecular interaction network suggested by
Ingenuity Pathway Analysis (IPA) ‘‘Core Analysis’’, with HNF4A
as a central node among other transcription and growth factors.
This network, associated with cancer, cellular development,
cellular growth and proliferation, consists of 17 of 23 input nodes,
each corresponding to the promoter of a RefSeq gene showing
differential methylation by HELP. Nodes are shaded in green for
relative hypermethylation in IUGR compared to controls, while
red-shaded nodes are hypomethylated in IUGR. The nodal
relationships are indicated by solid lines (direct interaction) and
dashed lines (indirect interactions), with or without filled arrows
indicating functional interaction or physical association, respec-
tively. The shape of each node indicates the class of molecule:
horizontal ovals are transcription factors, squares are growth
factors, vertical rectangles are ion channels, triangles are
phosphatases, diamonds are enzymes, trapezoids are transporters,
and circles correspond to ‘‘other’’ molecules with concentric circles
indicated complexes. In alphabetical order, this network consists of
ADCY5, ARPC4, ATG5, b-estradiol, BUD31, C11ORF10,
C9ORF5, Ca2+, CDKN2A, CHCHD8, CPA2, CPN1, CRY1,
CTNNBL1, CUX2, FSH, GATA2, GH1, GINS3, GRIK4,
HNF4A, INO80D, NCOR2, PPP3CA, PRSS3, RUVBL2,
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TP53, and TSKU.
Found at: doi:10.1371/journal.pone.0008887.s004 (0.46 MB TIF)
Figure S5 Technical validation studies using MassArray confirm
HELP data. Four loci were identified, two each representing
constitutively hypo- and hyper-methylated sites. The hypomethy-
lated sites were located at chr12:63986847-63987489 and
chr20:45414330-45414885, with hypermethylated sites at chr4:
188493650-188494271 and chr7:69549255-69549831 (hg18, hu-
man genome, March 2006, UCSC Genome Browser). HELP data
as log2(HpaII/MspI) ratios are shown along the x-axis, with
methylation towards the left and hypomethylation towards the
right. MassArray data for the same loci are plotted along the y-axis,
from 0% (hypomethylated) to 100% (methylated).
Found at: doi:10.1371/journal.pone.0008887.s005 (0.03 MB TIF)
Table S1 Neonatal and Maternal Characteristics for IUGR and
Controls
Found at: doi:10.1371/journal.pone.0008887.s006 (0.03 MB
DOC)
Table S2 Characteristics of top 56 candidate loci identified by
HELP. All positions correspond to coordinates in the human
genome, hg18 March 2006 UCSC Genome Browser; IUGR and
Control data given as group averages of log2(HpaII/MspI);
difference is IUGR minus Control; P-values are all x10
26; CpG,
overlap with CpG islands; CGc overlap CG clusters; phC overlap
with mammalian or vertebrate phastCons conserved elements;
Rep overlap with repetitive elements (RT for retrotransposable
elements including LINEs and SINEs, LT for long terminal
repeats); Loc overlap with promoters (PRO), bidirectional
promoters (PRO
2), or gene bodies (GB) of RefSeq genes; Gene
names and corresponding RefSeq identifiers are also shown.
Found at: doi:10.1371/journal.pone.0008887.s007 (0.04 MB
DOC)
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